CyberActa

Insights

SaMD AI/ML

AI/ML-based Software as a Medical Device cybersecurity and regulatory compliance consulting.

Artificial Intelligence and Machine Learning (AI/ML)-based Software as a Medical Device (SaMD) represents one of the most rapidly evolving areas in healthcare technology. The FDA has issued guidance on AI/ML-based SaMD, and CyberActa helps organizations navigate these requirements.

Our services for AI/ML SaMD include pre-submission meeting preparation, algorithm change protocols, predetermined change control plans, and post-market performance monitoring strategies aligned with FDA's action plan for AI/ML-based SaMD.

We work with your development and regulatory teams to ensure that your AI/ML-based SaMD meets both cybersecurity and regulatory requirements throughout its lifecycle.

CyberActa

Strategic Cybersecurity & Privacy Solutions

Legal

Your Privacy & Data Security

Copyright © 2020-2026 CyberActa, Inc. — All Rights Reserved.